InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

Current share price for NOX : $0.076 0.004 (5%)+

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Positive DARRT-1 Data in Late-Stage Prostate Cancer 2 Dec 2019 10:51AM $0.325 $0.076 fallen by 76.62%
$23 Trading Halt 28 Nov 2019 8:55AM $0.325 $0.076 fallen by 76.62%
$23 Lodgement of Nyrada Inc Prospectus - Initial Public Offering 26 Nov 2019 5:06PM $0.325 $0.076 fallen by 76.62%
$23 Constitution 20 Nov 2019 3:33PM $0.360 $0.076 fallen by 78.89%
$23 Updated Share Trading Policy 20 Nov 2019 3:31PM $0.360 $0.076 fallen by 78.89%
$23 Results of Meeting 20 Nov 2019 2:38PM $0.360 $0.076 fallen by 78.89%
$23 Noxopharm 2019 AGM Corporate Presentations 20 Nov 2019 9:13AM $0.350 $0.076 fallen by 78.29%
$23 DARRT-1 Interim Data Presented To Conference 12 Nov 2019 12:02PM $0.375 $0.076 fallen by 79.73%
$23 LuPIN Data Being Presented To Conference 12 Nov 2019 11:51AM $0.375 $0.076 fallen by 79.73%
$23 Appointment of Chief Commercial Officer 6 Nov 2019 9:14AM $0.400 $0.076 fallen by 81%
$23 Noxopharm October 2019 Newsletter 30 Oct 2019 9:49AM $0.370 $0.076 fallen by 79.46%
$23 Appendix 4C - Quarterly 30 Oct 2019 9:37AM $0.370 $0.076 fallen by 79.46%
$23 Dr Graham Kelly to Assume CEO Role 28 Oct 2019 9:18AM $0.395 $0.076 fallen by 80.76%
$23 Appendix 3B 25 Oct 2019 5:11PM $0.395 $0.076 fallen by 80.76%
$23 Section 708 Certificate 25 Oct 2019 5:11PM $0.395 $0.076 fallen by 80.76%
$23 NOX and Nyrada TechKnow Invest Roadshow Presentations 22 Oct 2019 8:51AM $0.400 $0.076 fallen by 81%
$23 Durable Anti-Cancer Effect Confirmed in DARRT-1 Study 21 Oct 2019 8:56AM $0.380 $0.076 fallen by 80%
$23 Notice of 2019 Annual General Meeting & Proxy Form 18 Oct 2019 4:20PM $0.380 $0.076 fallen by 80%
$23 Potential Fundamental Change in Treatment of Brain Cancer 18 Oct 2019 9:28AM $0.350 $0.076 fallen by 78.29%
$23 New Executive Appointments and Board Change 16 Oct 2019 10:15AM $0.370 $0.076 fallen by 79.46%
$23 Final Director's Interest Notice 16 Oct 2019 10:12AM $0.370 $0.076 fallen by 79.46%
$23 Noxopharm 2019 Annual General Meeting Details 2 Oct 2019 11:41AM $0.395 $0.076 fallen by 80.76%
$23 FNN Interview with Graham on recent LuPIN interim data 2 Oct 2019 9:36AM $0.405 $0.076 fallen by 81.23%
$23 Further Review Shows Major Clinical Benefits from Veyonda 30 Sep 2019 10:20AM $0.360 $0.076 fallen by 78.89%
$23 Annual Report to Shareholders 26 Sep 2019 10:17AM $0.385 $0.076 fallen by 80.26%

476 - 500 of 794 results

Page 20 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.